You Position: Home > Paper

Effect of rosiglitazone on leptin of type 2 diabetes patients complicated by non alcoholic fatty liver

( views:262, downloads:24 )
Author:
No author available
Journal Title:
CHINA MEDICINE
Issue:
8
DOI:
10.3760/cma.j.issn.1673-4777.2006.08.005
Key Word:
2型糖尿病;非酒精性脂肪肝;瘦素;罗格列酮

Abstract: 目的 探讨罗格列酮对2型糖尿病合并非酒精性脂肪肝患者瘦素水平的影响.方法 60例2型糖尿病合并非酒精性脂肪肝患者分为治疗组和对照组,治疗组使用罗格列酮4 mg/d,治疗3个月;治疗前后测定空腹、餐后血糖,空腹、餐后胰岛素,血脂、瘦素水平和肝功能,并观察体质指数、腰臀比、胰岛素抵抗指数.结果 治疗组瘦素、胰岛素、血糖、甘油三酯、低密度脂蛋白胆固醇明显下降,与对照组相比差异有显著性.结论 罗格列酮能降低2型糖尿病合并非酒精性脂肪肝患者的瘦素水平,改善胰岛素抵抗.

WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn